Are post-therapeutic SPECT/CT acquisitions useful to predict response to PRRT in patients with gastroenteropancreatic neuroendocrine tumors ? Preliminary results

被引:0
|
作者
Godefroy, T. [1 ]
Ansquer, C. [1 ]
Touchefeu, Y. [1 ]
Barbaud, M. [1 ]
Matysiak-Budnik, T. [1 ]
Kraeber-Bodere, F. [1 ]
Carlier, T. [1 ]
机构
[1] CHU Nantes, Nantes, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-143
引用
收藏
页码:S578 / S579
页数:2
相关论文
共 35 条
  • [21] Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
    Amir Sabet
    James Nagarajah
    Ahmet Semih Dogan
    Hans-Jürgen Biersack
    Amin Sabet
    Stefan Guhlke
    Samer Ezziddin
    EJNMMI Research, 3
  • [22] Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
    Sabet, Amir
    Nagarajah, James
    Dogan, Ahmet Semih
    Biersack, Hans-Juergen
    Sabet, Amin
    Guhlke, Stefan
    Ezziddin, Samer
    EJNMMI RESEARCH, 2013, 3 : 1 - 6
  • [23] Diagnostic Performance and Therapeutic Influence of Triple-Phase Contrast-Enhanced DOPA-PET/CT in Patients with Neuroendocrine Tumors - Initial Results
    Veit-Haibach, P.
    Strobel, K.
    Soyka, J.
    Buck, A.
    Hany, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S147 - S147
  • [24] The value of additional 131I SPECT/CT in characterizing inconclusive uptakes distant from the neck on post-therapeutic planar whole-body scintigraphy at the first radioablation in patients with differentiated thyroid cancer
    Chae, Sun-Young
    Kim, Hye Ok
    Na, Sae Jung
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Ryu, Jin-Sook
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] A dose-escalation-study evaluating the toxicity and therapeutic efficacy of 111In-DTPA-D-Phe1-octreotide in patients with metastatic neuroendocrine tumors:: Preliminary results.
    Schipper, ML
    Gotthardt, M
    Behe, M
    Diedrich, J
    Wied, MU
    Hoeffken, H
    Gratz, S
    Schlieck, A
    Arnold, R
    Behr, TM
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 315P - 316P
  • [26] Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
    Darejan Mamulashvili Bessac
    Philippe Baltzinger
    Nathan Poterszman
    Floriane Pham Van
    Cedric Collen
    Gabriel G. Malouf
    Eric Ouvrard
    Ashjan Kaseb
    Clemence Porot
    Meher Ben Abdelghani
    Pietro Addeo
    Luc Mertz
    Bernard Goichot
    Alessio Imperiale
    Endocrine, 2025, 87 (3) : 1333 - 1341
  • [27] Gallium-68 Dotatate PET/CT (Ga68PET/CT) Versus Contrast Enhanced Cross Sectional Imaging (CECSI) to Measure Treatment Response (TR) to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Neuroendocrine Tumors (NETs)
    Jackson, D.
    Downey, M.
    Kalish, G.
    Mittra, E.
    Kennecke, H.
    PANCREAS, 2021, 50 (03) : 454 - 454
  • [28] [68Ga]-DOTA-TOC PET-TC prospective comparison with [99mTc]-HYNIC-TOC SPECT-CT and [18F]-FDG PET-CT in patients with low grade gastroenteropancreatic neuroendocrine tumors (GEPNETs)
    Simo, M.
    Garcia, A.
    Hernando, J.
    Villasboas, D.
    Dellepiane, F.
    Navales, I.
    Barios, M.
    Boronat, M.
    Capdevila, J.
    Castell, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S582 - S582
  • [29] Standardized Uptake Value Calculated from 111In-Ibritumomab Tiuxetan SPECT/CT is a Very Useful Predictor for Therapeutic Efficacy and Post-Treatment Neutropenia in Patients Treated by 90Y-IT
    Kume, Ayaka
    Toriihara, Akira
    Shimizu, Ryo
    Harata, Naoki
    Isogai, Jun
    Tanaka, Hiroaki
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S312 - S312
  • [30] 68Ga-DOTA-TATE PET-CT Comparison with 99mTc-HYNIC-TOC SPECT-CT in the Assessment of the Extent of the Disease in Patients with Malignant Endocrine Tumors: Our Experience (Preliminary Results)
    Szalus, N.
    Pawlak, D.
    Dziuk, M.
    Koza, M.
    Kaminski, G.
    Podgajny, Z.
    Dziuk, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 60 - 61